Clairo

Project Manager, eCOA

Costa Rica

Not SpecifiedCompensation
Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
PharmaceuticalsIndustries

Requirements

Candidates should possess a Bachelor’s degree and/or proven Project Management skills or experience within the industry, along with 1-4 years of experience in project management, preferably in the pharmaceutical field or a related industry, and ideally experience within eCOA or similar products. Knowledge of the Software Development Life Cycle (SDLC) and the drug development process is required, as well as excellent organizational, interpersonal, time management, and prioritization skills. Detail orientation, responsiveness, and excellent verbal and written communication skills in English are also necessary. A valid passport and the ability to travel approximately 20% are required.

Responsibilities

The Project Manager, eCOA will be responsible for directing and managing services for client projects to assure high quality, on-time, and on-budget services while promoting excellent customer service. This includes leading the Planning and Setup, Monitoring, and Closeout phases of study management, gathering customer requirements, developing study documentation, distributing equipment, creating/distributing reports, archiving study data, and appropriately setting and fulfilling customer expectations. They will also monitor study timelines and manage the financial components of each program/study, including budget reviews, revenue forecasting, scope changes, invoice reconciliation, and identifying potential study risks and mitigations. Furthermore, the Project Manager will manage internal/external negotiations, promote collaboration, and apply problem-solving strategies to address customer issues and maintain issue tracking documentation. They will also ensure compliance with timely training completion/documentation, present study services at Investigator Meetings or site initiation meetings, assist with training new team members, and perform other duties as needed.

Skills

Project Management
Study Planning
Study Monitoring
Study Closeout
Customer Requirements Gathering
Study Documentation
Report Distribution
Data Archiving
Budget Management
Revenue Forecasting
Scope Management
Invoice Reconciliation
Risk Management
Negotiation
Collaboration
Problem Solving
Issue Tracking
Training
Presentation

Clairo

Generates clinical evidence for trials

About Clairo

Clario specializes in generating clinical evidence for medical research by utilizing a comprehensive technology platform. Their services support various types of clinical trials, including decentralized, hybrid, and site-based trials. Clario's approach combines nearly 50 years of experience with a vast network of facilities across nine countries, allowing them to conduct a significant number of clinical trials and regulatory approvals. What sets Clario apart from competitors is their extensive expertise and the ability to provide a wide range of endpoint technologies, which enhances the quality of evidence produced. The company's goal is to empower partners in the healthcare industry to improve patient outcomes through reliable and rich clinical data.

Key Metrics

London, United KingdomHeadquarters
1972Year Founded
$29.9MTotal Funding
GROWTH_EQUITY_VCCompany Stage
Biotechnology, HealthcareIndustries
5,001-10,000Employees

Benefits

Competitive and equitable total rewards package
Physical, mental and financial health and wellness
Flexible working approach

Risks

Increased competition from AI-driven platforms like Medable may threaten Clario's market share.
The IPO filing may lead to investor pressure for rapid financial returns, affecting strategy.
AI integration from ArtiQ poses data privacy and compliance risks, especially in the EU.

Differentiation

Clario offers a comprehensive endpoint technology platform for diverse clinical trial models.
The company has nearly 50 years of experience in clinical trial technology solutions.
Clario's global presence includes 30 facilities across North America, Europe, and Asia Pacific.

Upsides

Clario's IPO aims for a valuation of over $10 billion, indicating strong market confidence.
The FDA clearance of SpiroSphere® with wireless ECG enhances Clario's clinical trial capabilities.
Clario's acquisition of ArtiQ boosts its AI capabilities in respiratory clinical trials.

Land your dream remote job 3x faster with AI